New Safety Measures for Codeine Liquid Preparations now in Effect.
Amendments to the Drug Schedules Regulation (DSR) under the Pharmacy Operations and Drug Scheduling Act (PODSA), moving certain Schedule I codeine containing liquid preparations to Schedule IA, are now in effect.
Prescriptions for certain codeine containing liquid preparations will now require a Controlled Prescription Program duplicate prescription form. As with all Controlled Prescription Program drugs, these preparations must also be stored in a time-delay safe.
Codeine is an opiate pain killer – most often used to treat mild to moderate pain – that has seen an increase in recreational abuse and diversion. Codeine containing cough syrup products are the most common type of preparations included in this change.
Rescheduling the codeine containing liquid preparations listed below to Schedule 1A will improve oversight of these drugs, increase barriers to their access, and help to address public safety concerns, including:
- Addiction and non-medical use of these drugs,
- Prescription forgeries for these drugs, and
- Pharmacy robberies and thefts targeting these drugs.
This change is intended to address important public safety concerns and will not negatively impact patient care or access in British Columbia.
Codeine Containing Liquid Preparations Included in Schedule Change
|2298708||ACETAMINOPHEN ELIXIR WITH 8MG CODEINE PHOSPHATE SYRUP|
|816027||PMS-ACETAMINOPHEN WITH CODEINE ELIXIR|
|2244079||DIMETANE EXPECTORANT C|
Considerations for Community Pharmacies
Managers of Community Pharmacies involved in the dispensing of any of the above codeine containing liquid preparations will be required to implement the following measures on or before January 2, 2020:
Storage of applicable codeine containing liquid preparations in a time-delay safe.
Require the use of CPP duplicate prescription forms when dispensing applicable codeine containing liquid preparations.